APO RESEARCH · REPORT
Biodefense
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
Product & engineering
Understand the product.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
Selected research
Industry Growth & Trends
Global Biodefense Industry Growth and Trends Forecast to 2032
Market perspective
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
According to APO Research, the global Biodefense market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Biodefense market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biodefense market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biodefense market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biodefense.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biodefense market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biodefense Market by Company
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Biodefense Segment by Type
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Biodefense Segment by Application
US Military Market
US Civilian Market
Non - US Market
Biodefense Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodefense market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodefense and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodefense.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biodefense companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others
Applications
- US Military Market
- US Civilian Market
- Non - US Market
Companies covered
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biodefense Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biodefense Market Size by Region (2021-2032)
- 1.4.1 Global Biodefense Market Size by Region (2021-2026)
- 1.4.2 Global Biodefense Market Size by Region (2027-2032)
- 1.5 Key Regions Biodefense Market Size (2021-2032)
- 1.5.1 North America Biodefense Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biodefense Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biodefense Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biodefense Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biodefense Market Size Growth Rate (2021-2032)
2 Biodefense Market by Type
- 2.1 Type Introduction
- 2.1.1 Anthrax
- 2.1.2 Smallpox
- 2.1.3 Botulism
- 2.1.4 Radiation/Nuclear
- 2.1.5 Others
- 2.2 Global Biodefense Market Size by Type
- 2.2.1 Global Biodefense Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biodefense Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biodefense Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biodefense Market Size by Regions
- 2.3.1 North America Biodefense Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biodefense Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biodefense Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biodefense Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biodefense Market Size Breakdown by Type (2021-2026)
3 Biodefense Market by Application
- 3.1 Type Introduction
- 3.1.1 US Military Market
- 3.1.2 US Civilian Market
- 3.1.3 Non - US Market
- 3.2 Global Biodefense Market Size by Application
- 3.2.1 Global Biodefense Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biodefense Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biodefense Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biodefense Market Size by Regions
- 3.3.1 North America Biodefense Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biodefense Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biodefense Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biodefense Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biodefense Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biodefense Industry Trends
- 4.2 Biodefense Industry Drivers
- 4.3 Biodefense Industry Opportunities and Challenges
- 4.4 Biodefense Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biodefense Revenue (2021-2026)
- 5.2 Global Biodefense Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biodefense Key Company Headquarters & Area Served
- 5.4 Global Biodefense Company, Product Type & Application
- 5.5 Global Biodefense Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biodefense Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biodefense Players Market Share by Revenue in 2025
- 5.6.3 2025 Biodefense Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Emergent Biosolutions
- 6.1.1 Emergent Biosolutions Company Information
- 6.1.2 Emergent Biosolutions Business Overview
- 6.1.3 Emergent Biosolutions Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Emergent Biosolutions Biodefense Product Portfolio
- 6.1.5 Emergent Biosolutions Recent Developments
- 6.2 Hytest
- 6.2.1 Hytest Company Information
- 6.2.2 Hytest Business Overview
- 6.2.3 Hytest Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Hytest Biodefense Product Portfolio
- 6.2.5 Hytest Recent Developments
- 6.3 GSK
- 6.3.1 GSK Company Information
- 6.3.2 GSK Business Overview
- 6.3.3 GSK Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 GSK Biodefense Product Portfolio
- 6.3.5 GSK Recent Developments
- 6.4 Sanofi
- 6.4.1 Sanofi Company Information
- 6.4.2 Sanofi Business Overview
- 6.4.3 Sanofi Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Sanofi Biodefense Product Portfolio
- 6.4.5 Sanofi Recent Developments
- 6.5 PharmAthene
- 6.5.1 PharmAthene Company Information
- 6.5.2 PharmAthene Business Overview
- 6.5.3 PharmAthene Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 PharmAthene Biodefense Product Portfolio
- 6.5.5 PharmAthene Recent Developments
- 6.6 Bavarian Nordic
- 6.6.1 Bavarian Nordic Company Information
- 6.6.2 Bavarian Nordic Business Overview
- 6.6.3 Bavarian Nordic Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Bavarian Nordic Biodefense Product Portfolio
- 6.6.5 Bavarian Nordic Recent Developments
- 6.7 SIGA Technologies
- 6.7.1 SIGA Technologies Company Information
- 6.7.2 SIGA Technologies Business Overview
- 6.7.3 SIGA Technologies Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 SIGA Technologies Biodefense Product Portfolio
- 6.7.5 SIGA Technologies Recent Developments
- 6.8 Arbutus Biopharma
- 6.8.1 Arbutus Biopharma Company Information
- 6.8.2 Arbutus Biopharma Business Overview
- 6.8.3 Arbutus Biopharma Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Arbutus Biopharma Biodefense Product Portfolio
- 6.8.5 Arbutus Biopharma Recent Developments
- 6.9 DynPort Vaccine
- 6.9.1 DynPort Vaccine Company Information
- 6.9.2 DynPort Vaccine Business Overview
- 6.9.3 DynPort Vaccine Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 DynPort Vaccine Biodefense Product Portfolio
- 6.9.5 DynPort Vaccine Recent Developments
- 6.10 Xoma Corporation
- 6.10.1 Xoma Corporation Company Information
- 6.10.2 Xoma Corporation Business Overview
- 6.10.3 Xoma Corporation Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Xoma Corporation Biodefense Product Portfolio
- 6.10.5 Xoma Corporation Recent Developments
- 6.11 Ichor Medical Systems
- 6.11.1 Ichor Medical Systems Company Information
- 6.11.2 Ichor Medical Systems Business Overview
- 6.11.3 Ichor Medical Systems Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Ichor Medical Systems Biodefense Product Portfolio
- 6.11.5 Ichor Medical Systems Recent Developments
- 6.12 Aeolus Pharmaceuticals
- 6.12.1 Aeolus Pharmaceuticals Company Information
- 6.12.2 Aeolus Pharmaceuticals Business Overview
- 6.12.3 Aeolus Pharmaceuticals Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Aeolus Pharmaceuticals Biodefense Product Portfolio
- 6.12.5 Aeolus Pharmaceuticals Recent Developments
- 6.13 Achaogen
- 6.13.1 Achaogen Company Information
- 6.13.2 Achaogen Business Overview
- 6.13.3 Achaogen Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Achaogen Biodefense Product Portfolio
- 6.13.5 Achaogen Recent Developments
- 6.14 Elusys Therapeutics
- 6.14.1 Elusys Therapeutics Company Information
- 6.14.2 Elusys Therapeutics Business Overview
- 6.14.3 Elusys Therapeutics Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Elusys Therapeutics Biodefense Product Portfolio
- 6.14.5 Elusys Therapeutics Recent Developments
- 6.15 Dynavax Technologies
- 6.15.1 Dynavax Technologies Company Information
- 6.15.2 Dynavax Technologies Business Overview
- 6.15.3 Dynavax Technologies Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Dynavax Technologies Biodefense Product Portfolio
- 6.15.5 Dynavax Technologies Recent Developments
- 6.16 Cleveland BioLabs
- 6.16.1 Cleveland BioLabs Company Information
- 6.16.2 Cleveland BioLabs Business Overview
- 6.16.3 Cleveland BioLabs Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Cleveland BioLabs Biodefense Product Portfolio
- 6.16.5 Cleveland BioLabs Recent Developments
- 6.17 Soligenix
- 6.17.1 Soligenix Company Information
- 6.17.2 Soligenix Business Overview
- 6.17.3 Soligenix Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Soligenix Biodefense Product Portfolio
- 6.17.5 Soligenix Recent Developments
- 6.18 Alnylam Pharmaceuticals
- 6.18.1 Alnylam Pharmaceuticals Company Information
- 6.18.2 Alnylam Pharmaceuticals Business Overview
- 6.18.3 Alnylam Pharmaceuticals Biodefense Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Alnylam Pharmaceuticals Biodefense Product Portfolio
- 6.18.5 Alnylam Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Biodefense Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biodefense Market Size by Country (2021-2026)
- 7.3 North America Biodefense Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biodefense Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biodefense Market Size by Country (2021-2026)
- 8.3 Europe Biodefense Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biodefense Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biodefense Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biodefense Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biodefense Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biodefense Market Size by Country (2021-2026)
- 10.3 South America Biodefense Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biodefense Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biodefense Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biodefense Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst